PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1074-1083

  Ferrari, Patrizia ^a   Ferrandi, M ^a   Tripodi, G ^a   Torielli, L ^a   Padoani, G ^a   Minotti, E ^a   Melloni, P ^a   Bianchi, G ^b  

^a Prassis Sigma Tau Research Institute   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA (3 FURYL) 5BETA ANDROSTANE 3BETA,14BETA,17ALPHA TRIOL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; KIDNEY; ORAL DRUG ADMINISTRATION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT;

ANDROSTANOLS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; CELLS, CULTURED; DOWN-REGULATION; ENZYME INHIBITORS; HEART RATE; HYPERTENSION; KIDNEY MEDULLA; MALE; MUTATION; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSFECTION;

EID: 0032982693     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Barber BR, Ferrari P, Bianchi G (1962) The Milan hypertensive strain: a description of the model, in Handbook of Hypertension (Ganten D and de Jong W eds) pp 316-345, Elsevier, Amsterdam.
2. Bianchi G, Tripodi G, Casari G, Salardi S, Barber B R, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, Pinna LA, Baralle FE and Ferrari P (1994) Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 91: 3999-4003.
3. + ATPase expression in cultured renal cells by incubation in hypertonic medium. Am J Physiol 262:C845-C853.
4. + -ATPase. Am J Physiol 269:F637-F643.
5. Casari G, Barlassina C, Cusi D, Zagato L, Mutrhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G and Bianchi G (1995) Association of the alpha-adducin locus with essential hypertension. Hypertension 25:320-326.
6. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
7. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera, Stella P, Troffa C, Zagato L and Bianchi G (1997) Polymorphism of α-adducin and salt-sensitivity in patients with essential hypertension. Lancet 349:1353-1357.
8. De Larco JE and Todaro GJ (1978) Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors an the effect of mouse sarcoma virus transformation. J Cell Physiol 94:335-342.
9. De Mendoca M, Grichois ML, Pernollet MG, Wauquier I, Trouillet-Thormann B, Meyer P, Devynck MA and Garay R (1988) Antihypertensive effect of Canrenone in a model where endogenous ouabain-like factors are present. J Cardiovasc Pharmacol 11:75-83.
10. Doris PA (1994) Ouabain in plasma from spontaneously hypertensive rats. Am J Physiol 266:H360-H364.
11. Doris PA, Hinojos CA, Oefner PJ, Sabatini S and Hayward-Lester A (1997) EDLF and sodium pump function in kidney and nephron segments from SHR and WKY (Abstract). Am J Hypertens 10:274A.
12. Ferrandi M, Ferrari P, Salardi S, Barassi P, Rivera R, Manunta P and Bianchi G (1997b) Influence of the hypertension related adducin polymorphism on the Na-K ATPase activity (Abstract). J Hypertens 5 (Suppl 4):S60.
13. Ferrandi M, Manunta P. Balzan S, Hamlyn JM, Bianchi G and Ferrari P (1997a) Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 30:886-896.
14. Ferrandi M, Minotti E, Salardi S, Florio M. Bianchi G and Ferrari P (1992) Ouabain-like factor in Milan hypertensive rats. Am J Physiol 263:F739-F748.
15. Ferrandi M, Tripodi G, Salardi S, Florio M, Modica R, Barassi P, Parenti P, Shainskaya A, Karlish S, Bianchi G and Ferrari P (1996) Renal Na-KATPase in genetic hypertension. Hypertension 28:1018-1025.
16. Ferrari P and Bianchi G (1995) Lessons from experimental genetic hypertension, in Hypertension: Pathophysiology, Diagnosis And Management, 2nd ed. (Laragh JH and Brenner BM eds) pp 1261-1279, Raven Press. New York.
17. Ferrari P, Ferrandi M, Minotti E, Duzzi L and Bianchi G (1993) Effect of canrenone and hydrochlorothiazide on the development of hypertension in rat models of genetic hypertension. J Hypertens 11 (Suppl 5): S330-S331.
18. Ferrari P, Torielli L, Ferrandi M, Padoani G, Duzzi L, Florio M. Conti F, Melloni P, Vesci L, Corsico N and Bianchi G (1998) PST 2238, a new antihypertensive compound antagonist of the long-term pressor effect of ouabain. J Pharm Exp Ther 285:83-94.
19. Finotti P and Palatini P(1981) Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium activated adenosine triphosphatase. J Pharmacol Exp Ther 217: 784-790.
20. Garay RP, Diez J, Nazaret C, Dagher G and Abitbol JP (1985) The interaction of canrenone with the Na, K-pump in human red blood cells. Naunyn Schmiedeberg's Arch Pharmacol 329:311-315.
21. Ghysel-Burton J and Godfraind T (1979) Stimulation and inhibition of the sodium pump by cardioactive steroids in relation to their binding sites and their inotropic effect on guinea-pig isolated atria. Br J Pharmacol 66:175-184.
22. Godfraind T, Castaneda-Hernandez G, Ghysel-Burton J and De Pover A (1983) Hypothesis for the mechanism of stimulation of the Na/K pump by cardiac glycosides. Role of endogenous digitalis-like factor. Curr Top Membr Transport 19:912-915.
23. Hammerton RW, Krzeminski KA, Mays RW, Ryan TA, Wollner DA and Nelson JW (1991) Mechanism for regulating cell surface distribution of Na-KATPase in polarized epithelial cells. Science (Wash DC) 254:847-850.
24. Hughes CA and Bennett V 1995) Adducin: a physical model with implications for function in assembly of spectrin-actin complex. J Biol Chem 270:18990-18996.
25. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
26. Mays RW, Siemers KA, Fritz BA, Lowe AW, van Meer G and Nelson WJ (1995) Hierarchy of mechanism involved in generating Na/K-ATPase polarity in MDCK epithelial cells. J Cell Biol 130:1105-1115.
27. +)ATPase and implications for the organization of membrane domains in polirarized cells. Nature (London) 328:533-536.
28. Pamnani MB, Whitehorn WV, Clough DL and Haddy FJ 91990) Effects of Canrenone on blood pressure in rats with reduced renal mass. Am J Hypertens 3:188-195.
29. + or ouabain. J Cell Physiol 106:85-97.
30. Quadri L, Bianchi G, Cerri A, Fedrizzi G, Ferrari P, Gobbini M, Melloni P, Sputore S and Torri M (1997) 17β-(3-Furyl)-5β-androstane-3β,14β,17α-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action. J Med Chem 40:1561-1564.
31. + -ATPase during chronic ouabain treatment. Am J Physiol 256:C75-C80.
32. + -ATPase regulation. J Biol Chem 260:12740-12743.
33. Smith TW (1988) Digitalis. Mechanism of action and clinical use. N Engl J Med 318:358-365.
34. + -ATPase α- and β-subunit mRNA and protein abundance in cultured renal proximal tubule cells. Am J Physiol 263:C436-C442.
35. Tripodi G, Szpirer C, Reina C, Szpirer J and Bianchi G (1997) Polymophism of γ-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55. Biochem Biophys Res Commun 237:685-689.
36. Tripodi G, Valtorta F, Torielli L, Chieregatti E. Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC and Bianchi G (1996) Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97:2815-2822.
37. + -ATPase activity in rat tissues, Int J Cardiol 40:95-100.
38. Woolfson RG and de Wardener HE (1996) Primary renal abnormalities in hereditary hypertension. Kidney Int 50:717-731.